Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04906863 · ClinicalTrials.gov registry record
Genetic Studies of Early-onset Dementia
A clinical trial of Dementia, Early Onset, sponsored by Columbia University.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT04906863: Recruiting study of Dementia, Early Onset, sponsored by Columbia University.
NCT04906863 is a study of Dementia, Early Onset that is actively recruiting participants, run by Columbia University. The registered enrollment target is 1,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04906863, a study of Dementia, Early Onset, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to identify genetic factors that contribute to risk and progression of early-onset dementia (loss of memory function before the age of 70 years) across all ethnic groups, including Alzheimer's Disease, mild cognitive impairment and other dementias.
Primary Outcome
Genetic factors will be measured through genome-wide genotyping arrays and/or whole-genome sequencing, and then correlated with Alzheimer disease and related phenotypes, such as cognitive impairment, functional impairment, and relevant biomarkers.
Conditions Studied
Interventions
- GENETIC Blood draw
- OTHER Neurocognitive testing
- OTHER Medical questionnaire
Study Locations (1)
New York
- Columbia University Irving Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2016-09-14 |
| Est. Completion | 2028-04-30 |
What NCT04906863 shows while recruiting
NCT04906863 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Dementia, Early Onset appearing as the primary indexed condition, and to 3 interventions - of which Blood draw is the first listed.
NCT04906863 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04906863 about?
NCT04906863 is a clinical study titled "Genetic Studies of Early-onset Dementia". The aim of this study is to identify genetic factors that contribute to risk and progression of early-onset dementia (loss of memory function before the age of 70 years) across all ethnic groups, including Alzheimer's Disease, mild cognitive impairment and other dementias.
What is the current status of trial NCT04906863?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2016-09-14. Estimated completion is 2028-04-30.
What conditions does trial NCT04906863 study?
This clinical trial studies the following conditions: Dementia, Early Onset.
What interventions are being tested in trial NCT04906863?
The interventions under investigation include: Blood draw (GENETIC), Neurocognitive testing (OTHER), Medical questionnaire (OTHER).
Who is sponsoring clinical trial NCT04906863?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04906863 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI